DK2408446T3 - Anvendelse af farmaceutiske sammensætninger, der indeholder mesembrenon - Google Patents
Anvendelse af farmaceutiske sammensætninger, der indeholder mesembrenon Download PDFInfo
- Publication number
- DK2408446T3 DK2408446T3 DK10710448T DK10710448T DK2408446T3 DK 2408446 T3 DK2408446 T3 DK 2408446T3 DK 10710448 T DK10710448 T DK 10710448T DK 10710448 T DK10710448 T DK 10710448T DK 2408446 T3 DK2408446 T3 DK 2408446T3
- Authority
- DK
- Denmark
- Prior art keywords
- mesembrenone
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- containing mesembrenone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Psychology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA200902003 | 2009-03-20 | ||
| PCT/IB2010/051132 WO2010106494A1 (en) | 2009-03-20 | 2010-03-16 | Use of pharmaceutical compositions containing mesembrenone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2408446T3 true DK2408446T3 (da) | 2019-12-09 |
Family
ID=42167479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10710448T DK2408446T3 (da) | 2009-03-20 | 2010-03-16 | Anvendelse af farmaceutiske sammensætninger, der indeholder mesembrenon |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8552051B2 (da) |
| EP (1) | EP2408446B1 (da) |
| AU (1) | AU2010224485B2 (da) |
| DK (1) | DK2408446T3 (da) |
| ES (1) | ES2759675T3 (da) |
| PL (1) | PL2408446T3 (da) |
| PT (1) | PT2408446T (da) |
| WO (1) | WO2010106494A1 (da) |
| ZA (1) | ZA201106703B (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8980338B2 (en) | 2009-03-20 | 2015-03-17 | H.L. Hall & Sons Limited | Sceletium extract and uses thereof |
| GB201101075D0 (en) | 2011-01-21 | 2011-03-09 | Labminds Ltd | Automated solution dispenser |
| HUE031652T2 (en) * | 2011-02-07 | 2017-07-28 | Scipharm Sarl | New composition for treating cystic fibrosis |
| PE20151332A1 (es) | 2013-02-19 | 2015-09-20 | Pfizer | Compuestos de azabencimidazol |
| AU2014324608B2 (en) | 2013-09-27 | 2019-08-08 | Justin SHER | Nutraceutical compositon for PDE4 inhibition, enhanced dopamine metabolism and long term potentiation |
| CA2941099A1 (en) * | 2014-02-28 | 2015-09-03 | Matthew L. Tripp | Phosphodiesterase inhibiting phytochemical compositions |
| JP6713982B2 (ja) | 2014-07-24 | 2020-06-24 | ファイザー・インク | ピラゾロピリミジン化合物 |
| KR102061952B1 (ko) | 2014-08-06 | 2020-01-02 | 화이자 인코포레이티드 | 이미다조피리다진 화합물 |
| CN107835712B (zh) | 2015-02-06 | 2021-09-10 | 莱伯曼兹有限公司 | 自动化溶液分配器 |
| WO2017089347A1 (en) | 2015-11-25 | 2017-06-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas |
| WO2019021196A1 (en) * | 2017-07-26 | 2019-01-31 | Hg&H Pharmaceuticals (Pty) Ltd | MESEMBRENOL AND / OR MESEMBRANOL FOR THE PROPHYLAXIS AND TREATMENT OF PATIENTS SUFFERING FROM EPILEPSY AND RELATED DISEASES |
| WO2021086345A1 (en) * | 2019-10-30 | 2021-05-06 | Plant Synergy Inc. | High yield extraction method for and products of kanna plants |
| US10864239B1 (en) | 2019-10-30 | 2020-12-15 | Plant Synergy Inc. | High yield extraction method for and products of kanna plants |
| TW202325275A (zh) | 2021-10-29 | 2023-07-01 | 美商感覺中樞治療公司 | 治療性生物鹼化合物之遞送 |
| WO2024207030A1 (en) | 2023-03-28 | 2024-10-03 | Stellenbosch University | Composition comprising a sceletium extract and uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3604112A1 (de) | 1986-02-10 | 1987-08-13 | Bernhard Dr Janiak | Pflanzenextrakte von mesembryanthemaceen sowie solche enthaltende schaedlingsbekaempfungsmittel und arzneimittel |
| US6271001B1 (en) | 1995-03-23 | 2001-08-07 | Bio Polymers Pty. Ltd. | Cultured plant cell gums for food, pharmaceutical, cosmetic and industrial applications |
| ZA974576B (en) | 1996-06-04 | 1998-02-04 | Farmarc Nederland Bv | Pharmaceutical composition. |
| SE9804064D0 (sv) | 1998-11-25 | 1998-11-25 | A & Science Invest Ab | Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| JP2003523741A (ja) | 2000-02-01 | 2003-08-12 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | Ｂｃｌ−２様ポリヌクレオチド、ポリペプチドおよび抗体 |
| GB0111579D0 (en) * | 2001-05-11 | 2001-07-04 | Holford & Associates Ltd | Oral supplement |
| WO2004032851A2 (en) | 2002-10-04 | 2004-04-22 | The Regents Of The University Of California | Screening and therapeutic methods relating to neurogenesis |
| US6969702B2 (en) | 2002-11-20 | 2005-11-29 | Neuronova Ab | Compounds and methods for increasing neurogenesis |
| ATE494904T1 (de) | 2002-11-20 | 2011-01-15 | Neuronova Ab | Verbindungen und verfahren zur erhöhung der neurogenese |
| US20040185429A1 (en) | 2002-12-09 | 2004-09-23 | Judith Kelleher-Andersson | Method for discovering neurogenic agents |
| US20040254152A1 (en) | 2003-04-17 | 2004-12-16 | Monje Michelle L. | Prevention of deficits in neurogenesis with anti-inflammatory agents |
| US7763588B2 (en) | 2003-06-13 | 2010-07-27 | The Salk Institute For Biological Studies | Method for increasing cognitive function and neurogenesis |
| WO2005017189A2 (en) | 2003-08-05 | 2005-02-24 | University Of Florida Research Foundation, Inc. | Neural cell assay |
| WO2006025920A2 (en) * | 2004-06-19 | 2006-03-09 | Human Biomolecular Research Institute | Modulators of central nervous system neurotransmitters |
| US8980338B2 (en) | 2009-03-20 | 2015-03-17 | H.L. Hall & Sons Limited | Sceletium extract and uses thereof |
-
2010
- 2010-03-16 EP EP10710448.1A patent/EP2408446B1/en active Active
- 2010-03-16 AU AU2010224485A patent/AU2010224485B2/en active Active
- 2010-03-16 PT PT107104481T patent/PT2408446T/pt unknown
- 2010-03-16 PL PL10710448T patent/PL2408446T3/pl unknown
- 2010-03-16 ES ES10710448T patent/ES2759675T3/es active Active
- 2010-03-16 US US13/256,686 patent/US8552051B2/en active Active
- 2010-03-16 WO PCT/IB2010/051132 patent/WO2010106494A1/en active Application Filing
- 2010-03-16 DK DK10710448T patent/DK2408446T3/da active
-
2011
- 2011-09-13 ZA ZA2011/06703A patent/ZA201106703B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20120041045A1 (en) | 2012-02-16 |
| EP2408446B1 (en) | 2019-09-11 |
| EP2408446A1 (en) | 2012-01-25 |
| PT2408446T (pt) | 2019-12-18 |
| US8552051B2 (en) | 2013-10-08 |
| WO2010106494A1 (en) | 2010-09-23 |
| AU2010224485A1 (en) | 2011-10-20 |
| ZA201106703B (en) | 2012-05-30 |
| AU2010224485B2 (en) | 2014-04-17 |
| PL2408446T3 (pl) | 2020-03-31 |
| ES2759675T3 (es) | 2020-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2408446T3 (da) | Anvendelse af farmaceutiske sammensætninger, der indeholder mesembrenon | |
| SMT201700008B (it) | Composizione farmaceutica | |
| SMT201600350B (it) | Composizioni farmaceutiche | |
| SMT201700095B (is) | Composizioni farmaceutiche per inalazione | |
| DK2498756T3 (da) | Tabletformuleringer af neratinibmaleat | |
| DK3156056T3 (da) | Farmaceutiske sammensætninger der består af sorbitanestere | |
| DK3097925T3 (da) | Farmaceutisk sammensætning | |
| BRPI1004940A2 (pt) | composição farmacêutica | |
| DOP2011000396A (es) | Composiciones novedosas | |
| DK3246018T3 (da) | Farmaceutisk sammensætning | |
| BRPI1012539A2 (pt) | composições farmacêuticas | |
| BR112012003263A2 (pt) | formulações intravenosas de antagonistas de neuroquinina-1 | |
| BRPI1015939A2 (pt) | composição farmacêutica | |
| DK2419096T3 (da) | Stabilisering af radiofarmaceutiske sammensætninger under anvendelse af ascorbinsyre | |
| DK2403512T3 (da) | Sammensætninger af polymer myrcen | |
| DK2654736T3 (da) | Hidtil ukendt farmaceutisk sammensætning | |
| EE201300005A (et) | Ravimkoostis | |
| IT1394400B1 (it) | Composizioni farmaceutiche | |
| BRPI1010690A2 (pt) | composições | |
| DK2391349T3 (da) | Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater | |
| DK2405972T3 (da) | Anvendelse af rosuvastatin lactoler som medikamenter | |
| BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados | |
| DK2493312T3 (da) | Farmaceutiske faststofsammensætninger, der indeholder en integrase- hæmmer | |
| DK2542224T3 (da) | Oral farmaceutisk sammensætning indeholdende dabigatranetexilat | |
| FR2958537B1 (fr) | Composition dentaire |